PAVmed Inc. (PAVM)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 1.5M 3M 4.5M Q2 '22: 689K Q3 '22: 565K Q4 '22: 377K Q1 '23: 634K Q2 '23: 800K Q3 '23: 1.5M Q4 '23: 2.5M Q1 '24: 3M Q2 '24: 3.8M Q3 '24: 4M Q4 '24: 3M Q1 '25: 2M Q2 '25: 1M Q3 '25: 29K Q4 '25: 71K Q1 '26: 85K Q2 '26: 112K Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

-300K -200K -100K 0 100K 200K 300K Q2 '22: -265K Q2 '22

Operating Income TTM

-105M -70M -35M 0 35M 70M 105M Q3 '21: -42.3M Q4 '21: -54.4M Q1 '22: -66M Q2 '22: -76.5M Q3 '22: -86.2M Q4 '22: -91.1M Q1 '23: -91.9M Q2 '23: -84.9M Q3 '23: -77M Q4 '23: -68.8M Q1 '24: -62.4M Q2 '24: -59.6M Q3 '24: -55.7M Q4 '24: -44.5M Q1 '25: -35.9M Q2 '25: -26.9M Q3 '25: -20.2M Q4 '25: -21.8M Q1 '26: -24.4M Q2 '26: -26.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-105M -70M -35M 0 35M 70M 105M Q3 '21: -41.9M Q4 '21: -50.3M Q1 '22: -57.8M Q2 '22: -71.8M Q3 '22: -85.7M Q4 '22: -89M Q1 '23: -90M Q2 '23: -79.1M Q3 '23: -70.6M Q4 '23: -64.2M Q1 '24: -61.5M Q2 '24: -57.7M Q3 '24: 24.3M Q4 '24: 39.8M Q1 '25: 74M Q2 '25: 72.9M Q3 '25: 3.1M Q4 '25: 401K Q1 '26: -18.6M Q2 '26: -12.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 2.5M 5M 7.5M Q2 '22: 954K Q3 '22: 2.4M Q4 '22: 3.6M Q1 '23: 4.6M Q2 '23: 6.3M Q3 '23: 6.4M Q4 '23: 6.4M Q1 '24: 6.8M Q2 '24: 6.8M Q3 '24: 6.4M Q4 '24: 4.8M Q1 '25: 3.1M Q2 '25: 1.5M Q3 '25: 180K Q4 '25: 217K Q1 '26: 278K Q2 '26: 359K Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-90M -60M -30M 0 30M 60M 90M Q3 '21: -30.5M Q4 '21: -40.6M Q1 '22: -43.7M Q2 '22: -59.6M Q3 '22: -70.9M Q4 '22: -71M Q1 '23: -75.1M Q2 '23: -65.2M Q3 '23: -57M Q4 '23: -52M Q1 '24: -48.8M Q2 '24: -47.7M Q3 '24: -45.5M Q4 '24: -33.6M Q1 '25: -22M Q2 '25: -11.5M Q3 '25: -3.6M Q4 '25: -5.2M Q1 '26: -6.2M Q2 '26: -7.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-90M -60M -30M 0 30M 60M 90M Q3 '21: -30.7M Q4 '21: -42.1M Q1 '22: -45.7M Q2 '22: -61.9M Q3 '22: -73.5M Q4 '22: -72.5M Q1 '23: -76.1M Q2 '23: -65.9M Q3 '23: -57.3M Q4 '23: -52.3M Q1 '24: -49M Q2 '24: -48M Q3 '24: -45.8M Q4 '24: -33.6M Q1 '25: -22M Q2 '25: -11.6M Q3 '25: -3.6M Q4 '25: -5.2M Q1 '26: -6.3M Q2 '26: -7.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 35M 70M 105M Q1 '16: 12.2M Q2 '16: 13M Q3 '16: 13.3M Q1 '21: 74M Q2 '21: 82.2M Q3 '21: 83.3M Q1 '22: 86.3M Q2 '22: 87M Q3 '22: 89.8M Q1 '23: 6.5M Q2 '23: 7M Q3 '23: 7.5M Q1 '24: 8.7M Q2 '24: 9.2M Q3 '24: 44.5M Q1 '25: 1.7M Q2 '25: 602.8K Q3 '25: 21.6M Q1 '26: 1.6M Q2 '26: 6.3M Q2 '16 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-27.00 -18.00 -9.00 0.00 9.00 18.00 27.00 Q1 '21: -0.52 Q2 '21: -0.54 Q3 '21: -0.58 Q4 '21: -0.66 Q1 '22: -0.73 Q2 '22: -0.88 Q3 '22: -1.02 Q4 '22: -15.03 Q1 '23: -17.61 Q2 '23: -19.42 Q3 '23: -21.51 Q4 '23: -9.19 Q1 '24: -9.03 Q2 '24: -8.12 Q3 '24: -4.30 Q4 '24: 11.74 Q1 '25: 24.46 Q2 '25: 3.57 Q3 '25: 1.84 Q4 '25: -5.63 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.